Three-dimensional localization of serine 2808, a phosphorylation site in cardiac ryanodine receptor. 2007

Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
Wadsworth Center, New York State Department of Health, Albany, New York 12201, USA.

Type 2 ryanodine receptor (RyR2) is the major calcium release channel in cardiac muscle. Phosphorylation of RyR2 by cAMP-dependent protein kinase A and by calmodulin-dependent protein kinase II modulates channel activity. Hyperphosphorylation at a single amino acid residue, Ser-2808, has been proposed to directly disrupt the binding of a 12.6-kDa FK506-binding protein (FKBP12.6) to RyR2, causing a RyR2 malfunction that triggers cardiac arrhythmias in human heart failure. To determine the structural basis of the interaction between Ser-2808 and FKBP12.6, we have employed two independent approaches to map this phosphorylation site in RyR2 by three-dimensional cryo-electron microscopy. In one approach, we inserted a green fluorescent protein (GFP) after amino acid Tyr-2801, and mapped the GFP three-dimensional location in the RyR2 structure. In another approach, the binding site of monoclonal antibody 34C was mapped in the three-dimensional structure of skeletal muscle RyR1. The epitope of antibody 34C has been mapped to amino acid residues 2,756 through 2,803 of the RyR1 sequence, corresponding to residues 2,722 through 2,769 of the RyR2 sequence. These locations of GFP insertion and antibody binding are adjacent to one another in domain 6 of the cytoplasmic clamp region. Importantly, the three-dimensional location of the Ser-2808 phosphorylation site is 105-120 A distance from the FKBP12.6 binding site mapped previously, indicating that Ser-2808 is unlikely to be directly involved in the binding of FKBP12.6 to RyR2, as had been proposed previously.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010449 Peptide Mapping Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases. Fingerprints, Peptide,Peptide Fingerprinting,Protein Fingerprinting,Fingerprints, Protein,Fingerprint, Peptide,Fingerprint, Protein,Fingerprinting, Peptide,Fingerprinting, Protein,Mapping, Peptide,Peptide Fingerprint,Peptide Fingerprints,Protein Fingerprint,Protein Fingerprints
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
November 2008, Biochemical and biophysical research communications,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
April 2008, Circulation research,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
January 2006, Cardiovascular research,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
March 2012, Circulation research,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
November 2005, The Journal of biological chemistry,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
March 2004, Circulation research,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
July 2006, Biophysical journal,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
April 2005, Circulation research,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
July 1999, The Journal of cell biology,
Xing Meng, and Bailong Xiao, and Shitian Cai, and Xiaojun Huang, and Fei Li, and Jeff Bolstad, and Ramon Trujillo, and Judith Airey, and S R Wayne Chen, and Terence Wagenknecht, and Zheng Liu
June 1991, The Journal of biological chemistry,
Copied contents to your clipboard!